X0202 4 2007-01-17 0 0000713275 PHARMOS CORP PARS 0001106607 JP MORGAN PARTNERS BHCA LP C/O J.P. MORGAN PARTNERS, LLC 270 PARK AVENUE, 39TH FLOOR NEW YORK NY 10017 0 0 1 0 Class A Common Stock 2845160 D Class A Common Stock 1636484 D Class A Common Stock 360982 D Class A Common Stock 182798 D Class A Common Stock 50529 D Class A Common Stock 20387 D Class A Common Stock 132823 D Class A Common Stock 461157 D Stock Option (Right to Purchase) 1.84 2007-01-17 4 A 0 20000 0 A 2007-01-16 Class A Common Stock 20000 20000 I See Footnote See Exhibit 99.1 The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners (BHCA), L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman), L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors A, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Cayman) II, L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown), L.P. The amount shown represents the beneficial ownership of the Issuer's equity securities by J.P. Morgan Partners Global Investors (Selldown) II, L.P. These stock options were granted to Srinivas Akkaraju as part of his Director's Compensation package. Mr. Akkaraju is obligated to exercise the options, and to transfer any shares issued under the stock options to JPM BHCA, at the request of JPM BHCA. 25% of these stock options will vest on 1/17/08. The remaining 75% of the stock options will vest in twelve (12) quarterly increments thereafter. J.P. Morgan Partners (BHCA), LLC By: John C. Wilmot Managing Director 2007-01-18